{"id":"mct-sr","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal distress"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Medium-chain triglycerides (MCTs) are fatty acids with 6-12 carbon chains that are more readily absorbed in the gastrointestinal tract compared to long-chain triglycerides. The sustained-release formulation extends the duration of MCT availability in the body, potentially improving bioavailability and reducing gastrointestinal side effects associated with standard MCT formulations.","oneSentence":"MCT-SR is a sustained-release formulation of medium-chain triglycerides designed to improve lipid absorption and nutritional support.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:20:25.156Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Nutritional support in malabsorption disorders"},{"name":"Lipid supplementation in patients with impaired fat digestion"}]},"trialDetails":[{"nctId":"NCT04189705","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2019-12-30","conditions":"Acute Gastritis, Chronic Gastritis","enrollment":392}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MCT-SR","genericName":"MCT-SR","companyName":"Korea Otsuka Pharmaceutical Co., Ltd.","companyId":"korea-otsuka-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MCT-SR is a sustained-release formulation of medium-chain triglycerides designed to improve lipid absorption and nutritional support. Used for Nutritional support in malabsorption disorders, Lipid supplementation in patients with impaired fat digestion.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}